Society of Nuclear Medicine and Molecular Imaging (SNMMI)

The Society of Nuclear Medicine and Molecular Imaging (SNMMI), formerly the Society of Nuclear Medicine, is a nonprofit scientific and professional organization that promotes the science, technology and practical application of nuclear medicine and molecular imaging (PET and SPECT). The bulk of nuclear imaging exams relate to oncology, about a third to cardiac imaging and the rest for a variety of protocols, including imaging inflammation and beta-amyloid plaques that cause Alzheimer's disease. 

FAPI PET/CT shows promise as a better radiotracer for cancer than 18F-FDG. It also can be used for detection of infection and inflammation.

VIDEO: 6 key advances in molecular imaging technology for PET and SPECT

Munir Ghesani, MD, President of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), system chief of nuclear medicine at Mount Sinai Health, explains recent advances in nuclear imaging technology.

September 30, 2022
Two examples of PSMA-PET scans showing numerous prostate cancer metastases spread throughout the body. Many of these smaller tumors would not have been detected on previous standard-of-care imaging. Photo on left courtesy of SNMMI, right University of Chicago. #PSMAPET

PSMA-PET is rapidly changing the standard of care for prostate cancer patients

Adoption of PSMA-PET has been swift because it can significantly improve prostate cancer detection and treatment. SNMMI President Munir Ghesani, MD, explains how.

August 26, 2022
Researchers have designed a new cardiac SPECT imaging system that could potentially deliver images much faster than current models. The team presented its findings at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), SNMMI 2022. #SNMMI22 #snmmi #SNMMI2022

The need for speed: New-look cardiac SPECT imaging system could be up to 100 times faster than current models

Researchers presented their proposed design of a self-collimating SPECT system at SNMMI 2022.

June 16, 2022
SNMMI abstract of the year, targeted radionuclide therapy

Targeted radionuclide alpha therapy study wins SNMMI's Abstract of the Year

The study touts the benefits of targeted radionuclide alpha therapy for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) who have not had success with other treatments.

June 15, 2022
SNMMI Image of the Year 68Ga-FAPI-46 PET/CT heart attack acute myocardial infarction

‘Image of the Year’ highlights the predictive power of a new PET imaging agent

The Society of Nuclear Medicine and Molecular Imaging has chosen its 2022 Image of the Year, and it’s one that is sure to interest anyone in the field of cardiac imaging.

June 15, 2022

Cutting radiation exposure in half during PET/CT using virtual CT scans

“High-quality artificial intelligence-generated images preserve vital information from raw PET images without the additional radiation exposure from CT scans,” experts involved in the study explained.

June 13, 2022

First ever full course of the latest MR-guided radiation therapy treatments completed at Henry Ford Health

The Detroit-based cancer institute achieved this landmark moment using the MRIdian A3i, which is the latest enhancement of the MRIdian system from ViewRay, Inc.

June 6, 2022
An example of a positive amyloid plaque PET nuclear brain scan. these tests can help identify Alzheimer's patients earlier so they can be prescribed drugs to treat the condition.

CMS coverage decision for Alzheimer's drug, related PET scans sparks concern in imaging community

In a statement released on April 14, MITA cautioned that the coverage decision will “severely limit patient access” to amyloid PET diagnostics and anti-amyloid monoclonal antibodies treatment.

April 18, 2022

Press Releases

Trimed Popup
Trimed Popup